# Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux

> **NCT00378027** · — · WITHDRAWN · sponsor: **The Cleveland Clinic**

## Conditions studied

- Pulmonary Embolism

## Interventions

- **DRUG:** Fondaparinux

## Key facts

- **NCT ID:** NCT00378027
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-08
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** enrollment criteria not met by PI patient population
- **Last updated:** 2017-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378027, "Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00378027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*